Raymond James & Associates Horizon Therapeutics Public LTD CO Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$98.98 - $115.74 $591,306 - $691,430	-5,974 Reduced 44.86%	7,342 $849,000
Q2 2023 Jul 25, 2023	SELL	$96.34 - $112.38 $11.9 Million - $13.9 Million	-123,688 Reduced 90.28%	13,316 $1.37 Million
Q1 2023 Apr 14, 2023	SELL	$107.32 - $113.5 $7.95 Million - $8.41 Million	-74,095 Reduced 35.1%	137,004 $15 Million
Q4 2022 Feb 08, 2023	SELL	$62.39 - $113.8 $1.17 Million - $2.13 Million	-18,679 Reduced 8.13%	211,099 $24 Million
Q3 2022 Oct 25, 2022	SELL	$58.92 - $84.67 $4.72 Million - $6.78 Million	-80,109 Reduced 25.85%	229,778 $14.2 Million

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $4.35 Million - $6.38 Million	54,811 Added 21.49%	309,887 $24.7 Million
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $3.85 Million - $4.89 Million	44,506 Added 21.14%	255,076 $26.8 Million
Q4 2021 Feb 08, 2022	BUY	$98.56 - $119.91 $4.47 Million - $5.43 Million	45,314 Added 27.42%	210,570 $22.7 Million
Q3 2021 Nov 02, 2021	BUY	$91.91 - $110.37 $1.55 Million - $1.86 Million	16,820 Added 11.33%	165,256 $18.1 Million
Q2 2021 Aug 11, 2021	BUY	$86.24 - $95.92 $419,385 - $466,458	4,863 Added 3.39%	148,436 $13.9 Million
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $2.46 Million - $3.27 Million	34,204 Added 31.27%	143,573 $13.2 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $2.13 Million - $2.69 Million	31,834 Added 41.06%	109,369 $8 Million
Q3 2020 Nov 04, 2020	BUY	$55.23 - $79.93 $2.36 Million - $3.41 Million	42,671 Added 122.39%	77,535 $6.02 Million
Q2 2020 Jul 28, 2020	SELL	$30.2 - $56.98 $501,531 - $946,266	-16,607 Reduced 32.26%	34,864 $1.94 Million
Q1 2020 Apr 21, 2020	SELL	$24.87 - $38.56 $327,910 - $508,413	-13,185 Reduced 20.39%	51,471 $1.53 Million
Q4 2019 Feb 12, 2020	SELL	$25.43 - $36.67 $23,421 - $33,773	-921 Reduced 1.4%	64,656 $2.34 Million
Q3 2019 Nov 07, 2019	SELL	$23.0 - $27.97 $36,317 - $44,164	-1,579 Reduced 2.35%	65,577 $1.79 Million
Q2 2019 Aug 06, 2019	BUY	$22.81 - $28.48 $1.53 Million - $1.91 Million	67,156 New	67,156 $1.62 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account